“Real-World Clinical Outcomes of Ujvira® (Trastuzumab Emtansine Biosimilar) in HER2-Positive Breast Cancer: A Retrospective Observational Study in Indian Patients”. Journal of Cancer Research Updates 14 (August 15, 2025): 114–120. Accessed May 6, 2026. https://www.neoplasiaresearch.com/index.php/jcru/article/view/854.